Cited by 178Sleep and related disordersSleep and Work-Related FatigueTraffic and Road Safety

The DOI matches its Crossref record; 84 of the 85 references it cites were found in a registry or an index.

In the Zzz Zone: The Effects of Z-Drugs on Human Performance and Driving

Open access
Gunja, Naren·2013·Journal of Medical Toxicology

Abstract

Despite their improved pharmacokinetic profile, the Z-drugs, zolpidem, zopiclone, and zaleplon, have a spectrum of adverse effects comparable to benzodiazepines. This review focuses on the impairment from Z-drugs on cognition, behavior, psychomotor performance, and driving ability. Z-drugs are short-acting GABA agonists that reduce sleep latency without disturbing sleep architecture. Bizarre behavioral effects have prompted warnings on the prescription, dispensation, and use of Z-drugs. Psychomotor impairment, falls, and hip fractures are more likely to occur with Z-drugs that have longer half-lives, that are taken at higher-than-recommended doses and when mixed with other psychoactive substances including alcohol. Zopiclone and higher doses of zolpidem are more likely to cause anterograde amnesia than zaleplon. Z-drugs, especially zolpidem, are associated with complex behaviors such as sleepwalking, sleep-driving, and hallucinations. Patients taking zopiclone and zolpidem have an increased risk of motor vehicle collisions, over double that of unexposed drivers. Driving impairment occurs with zopiclone and higher doses of zolpidem but is unlikely to occur after 4 h post-zaleplon administration. The residual effect of Z-drugs on next-day cognitive and psychomotor performance has significant impact on lifestyle, safety, and occupational considerations, including motor vehicle and machine operation. The risk-benefit analysis of Z-drugs in the treatment of insomnia, particularly in the elderly, may not favor treatment due to the increased risks of falls and motor vehicle collisions. Prescribers should warn patients taking Z-drugs of minimum time thresholds before they operate machinery or drive motor vehicles.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s13181-013-0294-y

Cites

84 of 84 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 85 references

Research works printed but not linked: 3

  1. Therapeutic Goods Administration (2007) Zolpidem and bizarre sleep related effects. Aust Adverse Drug React Bull 26(1):2–3, http://www.tga.gov.au/pdf/aadrb-0702.pdf
  2. Riedel WJ, Vermeeren A, Van Boxtel MPJ et al (1998) Mechanisms of drug-induced driving impairment: a dimensional approach. Hum Psychopharmacol Clin Exp 13(S2):S49–S63 · DOI
  3. Weiss KJ, Del Busto E (2010) Sleep-driving and pathological intoxication: saved by the FDA? Am J Forensic Psychiatry 31(1):5–15

Cited by

Sorted by citations

See all 178

Metadata

Authors
Gunja, N.
Affiliations
Children's Hospital at Westmead (AU)
Corresponding author
Gunja, Naren
Venue
Journal of Medical Toxicology
Published
2013-03-02
Volume
9
Issue
2
Pages
163-171
ISSN
  • 1556-9039 (ISSN-L)
  • 1937-6995
OpenAlex
W1966792529
Cited by
177
References
85
Citations by year
2026: 5 · 2025: 6 · 2024: 5 · 2023: 14 · 2022: 16 · 2021: 11 · 2020: 35 · 2019: 19 · 2018: 13 · 2017: 12 · 2016: 13 · 2015: 11 · 2014: 16 · 2013: 1
FWCI
2.26
Type
journal article
Language
en
Open access
Locations
  • Journal of Medical Toxicology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and Work-Related Fatigue
  • Physical Sciences › Engineering › Safety, Risk, Reliability and Quality › Traffic and Road Safety
Keywords
Z-drugs, zolpidem, zopiclone, zaleplon, driving impairment, psychomotor performance, cognitive impairment, anterograde amnesia, sleepwalking, hallucinations, falls, hip fracture, traffic accidents, alcohol-drug interactions, insomnia treatment, elderly patients, benzodiazepine adverse effects, GABA agonists
MeSH terms
Zolpidem, Acetamides, Automobile Driving, Humans, Hypnotics and Sedatives, Piperazines, Psychomotor Disorders, Psychomotor Performance, Pyridines, Pyrimidines, Azabicyclo Compounds, GABA-A Receptor Agonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review